@article{27404,
  keywords = {Zero leprosy transmission, Transmission, Strategy, leprosy},
  author = {Smith WC and Aerts A and Kita E and Virmond M},
  title = {Time to define leprosy elimination as zero leprosy transmission?},
  abstract = {<p>In 1982, in response to growing evidence of resistance to the antibacterial drug, dapsone, WHO recommended that all patients with leprosy be treated with a short-course combination of three antibacterial drugs, rifampicin, dapsone, and clofazimine.<sup>1</sup> This multidrug therapy reduced the number of patients with leprosy being treated from 5{\textperiodcentered}3 million in 1985 to 3{\textperiodcentered}1 million in 1991.<sup>2</sup> The reduction in prevalence inspired the World Health Assembly in 1991 to set a target to eliminate leprosy as a public health problem by 2000, defining elimination as a global prevalence rate below one case per 10 000 of the population.</p>

<p>\&nbsp;</p>

<p>\&nbsp;</p>

<p>\&nbsp;</p>
},
  year = {2016},
  journal = {The Lancet. Infectious diseases},
  volume = {16},
  issn = {14733099},
  url = {http://www.thelancet.com/journals/laninf/article/PIIS1473-3099(16)00087-6/fulltext},
  doi = {10.1016/S1473-3099(16)00087-6},
}